Antagoniste 5HT3

Also known as 5HT3 antagonist, 5-HT3 antagonists, setron, setrons, Serotonin 5-HT3 Receptor Antagonists, 5-HT3 Antagonists, 5-HT3 Antagonist, 5-HT3 receptor antagonists

Research

10,029 papers

5-HT3 receptors.Current pharmaceutical design · 2006
Chemotherapy-Induced Nausea and Vomiting: Pathogenesis, Recommendations, and New Trends.Cancer treatment and research communications · 2021
Combination of 5-HT3 Antagonist and Dexamethasone Is Superior to 5-HT3 Antagonist Alone for PONV Prophylaxis After Laparoscopic Surgeries: A Meta-analysis.Anesthesia and analgesia · 2016
Olanzapine combined with 5-hydroxytryptamine type 3 receptor antagonist (5-HT3 RA) plus dexamethasone for prevention and treatment of chemotherapy-induced nausea and vomiting in high and moderate emetogenic chemotherapy: a systematic review and meta-analysis of randomised controlled trials.ESMO open · 2020
Granisetron, a selective 5-HT3 antagonist, reduces L-3,4-dihydroxyphenylalanine-induced abnormal involuntary movements in the 6-hydroxydopamine-lesioned rat.Behavioural pharmacology · 2021

via PubMed

Wikidata facts

Show 1 more fact

Article · Français

Les antagonistes 5HT3 sont des molécules antiémétiques agissant comme antagoniste des récepteurs sérotoninergiques (récepteurs de la sérotonine ou 5-hydroxytryptamine, 5-HT) de type 3. Ces composés sont ainsi utilisés comme médicament pour contrôler les nausées et vomissements induits par la chimiothérapie ou la radiothérapie. Ils sont administrés juste avant ces traitements.

Abstract from DBpedia / Wikipedia · CC BY-SA